CareSource Indiana invested $500,000 in MyBiometry to enhance chronic disease management and improve equitable healthcare access in the state.
Information on the Target
CareSource Indiana is committed to advancing healthcare initiatives that effectively address the health and social needs of its members and the broader community. In 2024, the organization has undertaken numerous innovative strategies aimed at overcoming obstacles to equitable care for Hoosiers. Key focus areas include improving access to healthcare, enhancing child welfare, managing chronic diseases, prioritizing maternal health, and addressing social determinants of health.
The organization has made significant investments, such as a $500,000 allocation towards MyBiometry, a project designed to enhance chronic disease management through advanced technology and real-time monitoring. This initiative is aimed at empowering individuals managing conditions like diabetes and hypertension, thereby improving their long-term health outcomes and quality of life.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Indiana
The healthcare landscape in Indiana is characterized by a diverse range of services and a growing emphasis on addressing health disparities. Despite progress, many communities in Indiana, especially rural ar
Similar Deals
Edwards Lifesciences → JenaValve Technology
2026
Fortified Health Security → Latitude Information Security
2026
LPOXY Therapeutics, Inc. → Xeno Biosciences Inc.
2025
CareSource Indiana
invested in
MyBiometry
in 2024
in a Other deal
Disclosed details
Transaction Size: $1M